References

Aeberli, I., G.A. Spinas, R. Lehmann, D. I'Allemand, L. Molinari and M.B. Zimmermann, 2009. Diet determines features of the metabolic syndrome in 6- to 14-year-old children. Int. J. Vitam. Nutr. Res., 79: 14-23.
CrossRef  |  PubMed  |  

Aekplakorn, W. and L. Mo-Suwan, 2009. Prevalence of obesity in Thailand. Obes. Rev., 10: 589-592.
PubMed  |  

Aekplakorn, W., J. Abbott-Klafter, A. Premgamone, B. Dhanamun and C. Chaikittiporn et al., 2007. Prevalence and management of diabetes and associated risk factors by regions of Thailand: Third National Health Examination Survey 2004. Diabetes Care, 30: 2007-2012.
PubMed  |  

Antuna-Puente, B., B. Feve, S. Fellahi and J.P. Bastard, 2008. Adipokines: The missing link between insulin resistance and obesity. Diabetes Metab., 34: 2-11.
CrossRef  |  

Banerjee, R.R., S.M. Rangwala, J.S. Shapiro, A.S. Rich and B. Rhoades et al., 2004. Regulation of fasted blood glucose by resistin. Science, 303: 1195-1198.
CrossRef  |  

Chaisiri, K., P. Pongpaew, R. Tungtrongchitr, B. Phonrat and S. Kulleap et al., 1997. Prevalence of abnormal glucose tolerance in Khon Kaen Province and validity of urine stick and fasting blood sugar as screening tools. J. Med. Assoc. Thai., 80: 363-371.
PubMed  |  

Chaisiri, K., P. Pongpaew, R. Tungtrongchitr, B. Phonrat and S. Kulleap et al., 1998. Nutritional status and serum lipids of a rural population in Northeast Thailand: An example of health transition. Int. J. Vitam. Nutr. Res., 68: 196-202.
PubMed  |  

Chanchay, S., R. Tungtrongchitr, T. Harnroongroj, B. Phonrat and O. Rungseesakorn et al., 2006. Plasma resistin, insulin concentration in non-diabetic and diabetic, overweight/obese Thai. Int. J. Vitam. Nutr. Res., 76: 125-131.
PubMed  |  

Cole, T.J., M.C. Bellizzi, K.M. Flegal and W.H. Dietz, 2000. Establishing a standard definition for child overweight and obesity worldwide: International survey. Br. Med. J., 320: 1240-1243.
CrossRef  |  PubMed  |  Direct Link  |  

Davutoglu, M., M. Ozkaya, E. Guler, M. Garipardic, H. Gursoy, H. Karabiber and M. Kilinc, 2009. Plasma visfatin concentrations in childhood obesity: Relationships with insulin resistance and anthropometric indices. Swiss Med. Wkly., 139: 22-27.
PubMed  |  

Fukuhara, A., M. Matsuda, M. Nishizawa, K. Segawa and M. Tanaka et al., 2005. Visfatin: A protein secreted by visceral fat that mimics the effects of insulin. Science, 307: 426-430.
CrossRef  |  Direct Link  |  

Gerber, M., A. Boettner, B. Seidel, A. Lammert and J. Bar et al., 2005. Serum resistin levels of obese and lean children and adolescents: Biochemical analysis and clinical relevance. J. Clin. Endocrinol. Metab., 90: 4503-4509.
CrossRef  |  

Haider, D.G., G. Holzer, G. Schaller, D. Weghuber and K. Widhalm et al., 2006. The adipokine visfatin is markedly elevated in obese children. J. Pediatr. Gastroenterol. Nutr., 43: 548-549.
PubMed  |  

Jin, H., B. Jiang, J. Tang, W. Lu and W. Wang et al., 2008. Serum visfatin concentrations in obese adolescents and its correlation with age and high-density lipoprotein cholesterol. Diabetes Res. Clin. Pract., 79: 412-418.
CrossRef  |  

Korner, A., A. Garten, M. Bluher, R. Tauscher, J. Kratzsch and W. Kiess, 2007. Molecular characteristics of serum visfatin and differential detection by immunoassays. J. Clin. Endocrinol. Metab., 92: 4783-4791.
CrossRef  |  

Korner, A., J. Kratzsch, R. Gausche, M. Schaab, S. Erbs and W. Kiess, 2007. New predictors of the metabolic syndrome in children: Role of adipocytokines. Pediatr. Res., 61: 640-645.
PubMed  |  

Lopez-Bermejo, A., B. Chico-Julia, M. Fernandez-Balsells, M. Recasens and E. Esteve et al., 2006. Serum visfatin increases with progressive beta-cell deterioration. Diabetes, 55: 2871-2875.
PubMed  |  

Matthews, D.R., J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher and R.C. Turner, 1985. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28: 412-419.
CrossRef  |  PubMed  |  Direct Link  |  

Morgan, C.R. and A. Lazarow, 1963. Immunoassay of Insulin: Two-antibody system. Plasma insulin levels of normal, subdiabetic and diabetic rats. Diabetes, 12: 115-126.

Nusken, K.D., E. Nusken, M. Petrasch, M. Rauh and J. Dotsch, 2007. Preanalytical influences on the measurement of visfatin by enzyme immuno assay. Clin. Chim. Acta, 382: 154-156.
PubMed  |  

Sethi, J.K. and A. Vidal-Puig, 2005. Visfatin: The missing link between intra-abdominal obesity and diabetes? Trends Mol. Med., 11: 344-347.
PubMed  |  Direct Link  |  

WHO, 2005. Preventing Chronic Diseases: A Vital Investment. World Health Organization, Geneva, Switzerland, ISBN-13: 9789241563000, Pages: 182.

WHO., 2006. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: Report of a WHO/IDF consultation. World Health Organization, Geneva, Switzerland.

Wallace, T.M., J.C. Levy and D.R. Matthews, 2004. Use and abuse of HOMA modeling. Diabetes Care, 27: 1487-1495.
CrossRef  |